REGULATED PRESS RELEASE published on 11/03/2023 at 06:52, 2 years 1 month ago SPIE - Press release - Quarterly information as at September 30th, 2023
REGULATED PRESS RELEASE published on 11/03/2023 at 06:52, 2 years 1 month ago SPIE - Communiqué de presse - Information trimestrielle au 30 septembre 2023
REGULATED PRESS RELEASE published on 10/05/2023 at 17:45, 2 years 1 month ago Information regarding the voting rights and shares - October 2023
REGULATED PRESS RELEASE published on 10/05/2023 at 17:45, 2 years 1 month ago Information mensuelle relative au nombre total de droits de vote - Octobre 2023
REGULATED PRESS RELEASE published on 10/02/2023 at 17:42, 2 years 2 months ago CP - SPIE renforce sa division Building Solutions aux Pays-Bas avec l’acquisition d’IMI Aero-Dynamiek
REGULATED PRESS RELEASE published on 10/02/2023 at 17:42, 2 years 2 months ago PR - SPIE expands its Building Solutions division in the Netherlands with the acquisition of IMI Aero-Dynamiek
Published on 12/05/2025 at 02:35, 4 hours 5 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 40 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 35 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 40 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 49 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 25 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 25 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL